Bristol Myers Squibb’s Post

“It really did let me know that there’s almost nothing I can’t accomplish if I’m not willing to put my head down and try.” Cari Almo Gallman, EVP, General Counsel and Chief Policy Officer, shares her inspirational story of facing adversity, including her mother’s illness, emphasizing the power of reframing challenges into resilience and strength. Watch the latest episode of Trials to Transformation to hear her story. https://bit.ly/4lxWtWU #TrialstoTransformation

Tom Sun .

Director to Senior Research Fellow, Bioanalysis & DMPK at Vertex Pharmaceuticals | Driving Innovative Drug Development through Cutting-Edge Pharmacokinetics

1w

Interesting

Like
Reply
Chris C.

Manager Drug Development | R&D Strategy | Translational Science

1w

Love this

Like
Reply
Mary chen

Research And Development Manager at Bristol Myers Squibb

6d

Thanks for sharing

Like
Reply

You’re such an inspiring woman Cari Almo Gallman. I really loved this touching story and very happy to hear your Mom is still with you!

What a touching story! Cari’s story is a powerful reminder that resilience and determination can turn even the toughest challenges into opportunities for growth. Many people might have folded in those challenging circumstances.

Like
Reply
Arlene Cheung

Marketing Director @ Gilead Sciences | Marketing, Product Promotion | Bachelor's Degree from PSSC Business School

1w

Thanks for sharing

"If you can't fix it, feature it." What an inspiring line! Thank you, Cari Almo Gallman, for sharing your touching story. You truly are such a resilient woman. 👏

Cari’s willingness to keep going, even when things were tough, speaks volumes. That kind of work ethic and mindset is everything. Thanks for sharing.

Like
Reply
Mary chen

Research And Development Manager at Bristol Myers Squibb

4d

Thanks for sharing

Like
Reply

Impressive shift from trials to transformation—clinical innovation is critical. But global expansion means global scrutiny. China’s cybersecurity and data localization laws are tightening fast, and non-compliance could disrupt patient studies and data integrity. Firms need partners like QTS Global to build secure, compliant trial infrastructure.

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics